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Abstract 21 
MLB astroviruses were identified 10 years ago in feces from children with 22 
gastroenteritis of unknown etiology, and have been unexpectedly detected in severe 23 
cases of meningitis/encephalitis, febrile illness of unknown etiology and respiratory 24 
syndromes. The aim of this study was to establish a cell culture system supporting MLB 25 
astrovirus replication. We used two clinical strains to infect several cell lines: a MLB1 26 
strain from a gastroenteritis case, and a MLB2 strain associated with a neurologic 27 
infection. Efforts to propagate the viruses in the CaCo-2 cell line were unsuccessful. In 28 
contrast, we identified two human non-intestinal cell lines, HuH-7 and A549 cell lines, 29 
permissive for both genotypes. After serial passages in the HuH-7.5 cell line, the 30 
adapted strains were able to establish persistent infections in HuH-7.5, HuH-7AI and 31 
A549 cell lines, with high viral loads (up to 10 log10 genome copies/ml) detected by 32 
RT-qPCR in the culture supernatant. Immunofluorescence assays demonstrated 33 
infection in about 10% of cells in persistently infected cultures. Electron microscopy 34 
revealed particles of 32-33 nm in diameter after negative staining of cell supernatants 35 
and capsid arrays in ultrathin sections with a particularly high production in HuH-7.5 36 
cells. IFN expression by infected cells and effect of exogenous IFN varied depending on 37 
the type of infection and the cell line. The availability of a cell culture system to 38 
propagate MLB astroviruses represents a key step to better understand their replicative 39 
cycle, as well as a source of viruses to conduct a wide variety of basic virologic studies. 40 
 41 
 42 
 43 
 44 
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Importance 45 
MLB astroviruses are emerging viruses infecting humans. More studies are required to 46 
determine their exact epidemiology, but several reports have already identified them as 47 
the cause of unexpected clinical diseases, including severe neurologic diseases. Our 48 
study provides the first description of a cell culture system for the propagation of MLB 49 
astroviruses, enabling the study of their replicative cycle. Moreover, we demonstrated 50 
the unknown capacity of MLB astrovirus to establish persistent infections in cell 51 
culture. Whether these persistent infections are also established in vivo still remains 52 
unknown, but the clinical consequences would be of high interest if persistence was 53 
confirmed in vivo. Finally, our analysis of the IFN expression provides some trails to 54 
understand the mechanism by which MLB astroviruses can cause persistent infections 55 
in the assayed cultures. 56 
 57 
Introduction 58 
Firstly identified in 1975 in stool samples of children with diarrhea (1), human 59 
astroviruses (HAstVs) cause viral gastroenteritis worldwide (2), being the third most 60 
common cause in the pediatric population, after rotavirus and norovirus. Besides 61 
children, HAstV gastroenteritis also frequently occurs in the elderly (3) and in 62 
immunocompromised individuals (4-6). They are small (28-41 nm in diameter), non-63 
enveloped, single-stranded positive sense RNA viruses. To date, the family Astroviridae 64 
is divided in two genera: Mamastrovirus and Avastrovirus, including viruses infecting 65 
mammals and birds, respectively. Their genome codes for three open reading frames 66 
(ORFs), with ORF1a and ORF1b encoding the protease and polymerase proteins, 67 
respectively, and ORF2 the capsid proteins.  68 
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With the advent of next-generation sequencing technologies, two novel groups of highly 69 
divergent HAstVs (named MLB and VA/HMO) which are more closely related to 70 
certain animal astroviruses than to the classic HAstVs have been identified in human 71 
stools of individuals with diarrhea (7-13), but also in asymptomatic healthy controls 72 
(14, 15). To date, no definitive association between novel astroviruses and 73 
gastroenteritis has yet been established, but further epidemiologic studies have 74 
confirmed the presence of novel HAstVs worldwide (14, 16-21). In addition, novel 75 
HAstVs have been recently identified as the cause of unexpected central nervous system 76 
infections in – mostly immunocompromised - humans (22-28). Specifically, MLB 77 
astroviruses have been involved in one case of acute meningitis in a healthy young adult 78 
(28), and in two cases of neurologic infections in immunocompromised patients (27, 79 
28). Both groups of novel HAstVs have been further divided into several genotypes: 80 
MLB1-3 for MLB astroviruses, and VA1-5 for VA astroviruses (2, 29).  81 
Novel HAstVs are part of the neurovirulent astroviruses, which also include animal 82 
astroviruses (30). Other unexpected clinical manifestations recently associated with 83 
human and animal astroviruses include respiratory tract infections (31-37), fever of 84 
unknown etiology (38, 39), hepatitis (40, 41), and severe gout in goose (42). Altogether, 85 
these findings suggest that there are probably other still unrecognized divergent 86 
astroviruses with clinical implications beyond gastroenteritis, in humans and animals. 87 
The potential for cross-species transmission is high (43, 44) and the increasing number 88 
of descriptions of non-enteric severe clinical manifestations in animals, especially 89 
neurologic involvement, should prompt us to validate appropriate systems to study the 90 
pathogenicity of astroviruses. Among the novel human astroviruses, a cell culture 91 
system has been recently described for VA1 (45). The present study aims at describing a 92 
cell culture system for the propagation of MLB1 and MLB2 astroviruses, the two MLB 93 
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genotypes most frequently identified, and providing some clues for understanding their 94 
pathogenicity. 95 
Results 96 
MLB astroviruses can be propagated in HuH-7.5 hepatoma cells 97 
Several MLB clinical specimens were used to infect different cell lines and perform 98 
serial viral passages (V-P), following a protocol for an acute infection (see Material and 99 
methods section). Three MLB1 strains were recovered from stool samples of children 100 
under 5 year old with symptoms of acute gastroenteritis and three MLB2 strains were 101 
recovered from stool samples and included a neuro-invasive strain identified in an 102 
immunocompromised adult patient (28). Among these, only two strains were able to 103 
replicate in cell culture (Figure 1): one MLB1 strain recovered from a 1-year-old child, 104 
and the MLB2 neuro-invasive strain recovered from the 37-year-old 105 
immunocompromised patient. Attempts to propagate these strains in CaCo-2 cell line 106 
resulted in loss of genome detection after 2 passages (Figure 2A). Using HuH-7.5 cells, 107 
we observed sustained viral genome detection in the culture supernatant (SN) for up to 108 
8-9 passages, and some viral passages were also successful in A549 cells (Figures 1A 109 
and 2A). Electron microscopy of the supernatant of acutely infected Huh7.5 cells 110 
confirmed the presence of viral capsids of both genotypes, of a mean size of 33±3 nm 111 
for MLB1 and 32±2 nm for MLB2 (Figures 2B and 2C). 112 
Multi-step growth curves were performed to define infection kinetics (Figure 3A and 113 
B). While increase of viral RNA in the cellular fraction showed a similar kinetic for 114 
both viruses, with a major increase during the first 2 days after inoculation and a total 115 
log10 fold increase from 1 hour post-infection (hpi) to 7 days post-infection (dpi) of 116 
3.41±0.37 for MLB1 and 3.22±0.49 for MLB2 (Figure 3A), increase of viral RNA in 117 
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the supernatant fraction was much higher for MLB2 than for MLB1 (5.14±0.03 vs 118 
2.99±0.20, p<0.05) (Figure 3B), resulting also in an overall higher viral production for 119 
MLB2. We also confirmed the occurrence of infectious viruses in the inoculum by 120 
treating it for 5 minutes at 99ºC and confirming the lack of viral RNA increase in the 121 
supernatant of infected cultures (data not shown).  122 
A trypsin treatment was initially included, but no significant differences were observed 123 
in the efficiency of MLB replication in the presence or absence of trypsin (5 µg/ml) in 124 
the post-infection medium (Figure 3C). 125 
 126 
MLB astroviruses can persistently infect cell cultures  127 
According to the high intracellular viral titer fraction observed for MLB1, we 128 
hypothesized that this could reflect a persistent infection. To ascertain whether infected 129 
cultures were able to regrow after infection, we used the MLB1 V-P7 cell lysate to 130 
establish a persistent infection in HuH-7.5 cell line. Infected cells were trypsinized at 4 131 
dpi and could be further maintained for up to at least 20 cell passages (C-P) (Figure 132 
1A). The presence of numerous capsid arrays in persistently-infected HuH-7.5 cells, 133 
mostly associated with cell membrane vesicles, was observed (Figure 4). Cells 134 
containing capsid arrays showed remarkable cell structure reorganizations. 135 
To elucidate if this was due to the described defect in the interferon pathway of HuH-136 
7.5 cell line (46, 47), we similarly initiated a persistent infection on HuH-7AI cells with 137 
both HAstV MLB1 and MLB2 strains recovered from cell lysates, and also on A549 138 
cells, according to the supposed respiratory tropism of novel astroviruses (Figure 1B). 139 
Titers of viral genomes for both strains detected in the supernatant of the two cell lines 140 
during passages of persistently infected cultures are shown in Figure 5A. The mean 141 
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viral titer for MLB1 was significantly higher than MLB2 in HuH-7AI and A549 cell 142 
lines (p<0.002; Figure 5B). MLB1 mean viral titer was also significantly higher in 143 
HuH-7.5 cells compared to HuH-7AI cells, which could confirm our initial hypothesis 144 
that the HuH-7.5 interferon pathway deficiency could promote MLB1 replication 145 
(p<0.001; Figure 5A).  146 
Attempts to establish a MLB2 persistent infection on HuH-7.5 cell line were however 147 
unsuccessful, and we decided to pursue the rest of the experiments on HuH-7AI and 148 
A549 cells only, in order to be able to compare the results between both genotypes. 149 
Except at 4 days after C-P0, persistently infected cultures did not show cytopathic 150 
effect, and cells were morphologically identical to non-infected cells. Of note, attempts 151 
to establish a persistent infection on CaCo-2 cells showed a progressive decline of the 152 
viral titer from one cell passage to another, reason why we did not pursue with this cell 153 
culture system neither (Figure 5A). 154 
Indirect immunofluorescence assays confirmed the presence of viral capsid proteins in 155 
infected cells. Figure 6A shows capsid protein formation in each cell line persistently 156 
infected by MLB1 and MLB2 strains. While the fluorescent intensity in each cell line 157 
reflects a high production of capsid protein in infected cells, the proportion of cells 158 
showing capsid proteins ranged between 1-18% (median 11% and 4.8% for HuH-7AI 159 
and A549 persistently infected with MLB1, respectively, and 8.8% for both cell lines 160 
persistently infected with MLB2) (Figure 6B). Overall, for HAstV MLB1, the 161 
percentage of capsid-expressing cells was significantly higher in HuH-7AI cells than in 162 
A549 cells. No differences were observed for HAstV MLB2. Electron microscopy also 163 
confirmed the presence of viral capsid arrays within HuH-7AI and A549 infected cells 164 
(Figure 7). Table 1 summarizes the results of HAstV MLB1 and MLB2 propagation on 165 
selected cell lines. 166 
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Complete genome sequences, using primers detailed in Table 2, were obtained for both 167 
strains to analyze whether mutations were occurring during replication compared to 168 
viral sequences present in the clinical specimens. The nucleotide sequences of wild-type 169 
strains recovered from clinical samples are available at Genbank (accession numbers 170 
MK089434 and MK089435). For MLB1, sequences were obtained at V-P6 and C-P2 of 171 
acute and persistent HuH-7.5 cell infections, respectively. For MLB2, sequences were 172 
obtained at V-P2 on A549 cells and V-P3 in HuH-7.5 cells. No nucleotide changes were 173 
detected on the whole genomes throughout the analyzed passages. Nevertheless, we 174 
could observe a A/C polymorphism at position 1313 and a C/T polymorphism at 175 
position 5477 of MLB2 at V-P2 in A549 cells, probably reflecting the presence of virus 176 
quasiespecies. While this latter mutation would be synonymous (and was also present in 177 
the wild-type strain), mutation at position 1313 would result in a substitution of a 178 
Lysine (K) residue by an Arginine (N) in ORF1a. Interestingly, HAstV MLB1 strain 179 
directly recovered from the stool sample was also able to establish a persistent infection 180 
in HuH-7.5 cell line, with viral titers comparable to the persistent infection with HAstV 181 
MLB1-adapted strain (Figure 5A), confirming that the ability to establish persistent 182 
infections in cell cultures is not dependent on any specific adaptative mutation.  183 
Lack of a strong type I interferon response in MLB-infected cultures 184 
We measured the expression of IFN-β and IFN-λ1, both known to be implicated in the 185 
antiviral innate response. PolyI:C transfection was used as a positive control of IFN 186 
induction and GAPDH mRNA levels were used for normalization. During the acute 187 
infection, we could not detect any expression of IFN-λ1, and only a low expression of 188 
IFN-β mRNA from 4 to 7 dpi in A549 cells infected with MLB1 and MLB2, compared 189 
to polyI:C control (Figure 8A). In order to confirm that the absence of IFN expression 190 
in HuH-7AI was not due to the fact that only a small proportion of these cells were 191 
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infected, we infected them with the highest multiplicity of infection possible according 192 
to the viral titer of the stocks (MOI 25,000 genome copies/cell for MLB1 and 680 193 
genome copies/cell for MLB2), which resulted in the infection of >80% of HuH-7AI 194 
cells (as visualized by immunofluorescence, Figure 8B and 8C), and IFN mRNA 195 
remained undetectable. During persistent infections, there was basically no expression 196 
of IFN-β nor IFN-λ1 mRNAs, in any of the two cell lines, infected with MLB1 or 197 
MLB2 (Figure 8D).  198 
To understand whether MLB1 and MLB2 replication could block type I IFN expression 199 
induced by dsRNA, we analyzed IFN-β and IFN-λ1 mRNA expression after transfecting 200 
polyI:C in persistently-infected cultures. We could observe that IFN-β and IFN-λ1 201 
mRNA expression was almost undetectable in A549 cells for both genotypes compared 202 
to positive control, while in HuH-7AI cell line, IFN-β and IFN-λ1 induction was only 203 
blocked by MLB2. MLB1 genotype slightly inhibited the expression of IFN-λ1 but not 204 
of IFN-β (Figure 8D). The possibility that A549 persistently infected cultures were 205 
refractory to transfection was ruled out by confirming that cells could be efficiently 206 
transfected using a green fluorescent protein (GFP)-encoding plasmid (data not shown). 207 
Altogether, these results suggest that MLB replication is able to disrupt the innate 208 
immune sensing pathway induced by polyI:C, although this behavior is cell and 209 
genotype (or strain)-dependent.  210 
Exogenous IFN inhibits viral replication in a cell-dependent manner 211 
Finally, we tested if the addition of exogenous IFN-β1a and IFN-λ1 at 1,000 U/ml could 212 
inhibit viral replication when acutely infected, and cure the persistently-infected cell 213 
lines. During acute infection, pre-treatment of cells with both IFN-β1a and IFN-λ1 214 
resulted in a statistically significant reduction in the viral titer, compared to mock-215 
treated controls (p<0.005 and p<0.01 for IFN-β1a and IFN-λ1, respectively, during 216 
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MLB1 infection of both cell lines; p<0.001 and p<0.005 for IFN-β1a and IFN-λ1, 217 
respectively, during MLB2 infection of both cell lines; Figure 9A and 9B). The 218 
inhibitory effect of both IFNs were higher in HuH-7AI cells compared to A549 cells 219 
(p=0.02). For both genotypes and in both cell lines, the effect of IFN-β1a was 220 
approximately two-fold higher compared to IFN-λ1 (average log10 reductions of 221 
2.91±0.11 versus 1.59±0.11 for MLB1 in HuH-7AI, 1.92±0.52 versus 0.94±0.11 for 222 
MLB1 in A549; 4.35±0.03 versus 2.30±0.25 for MLB2 in HuH-7AI; and 2.64±0.20 223 
versus 1.33±0.02 for MLB2 in A549). 224 
 225 
During persistent infection, the addition of IFN-β1a to the culture media succeeded in 226 
curing the HuH-7AI cell culture from both MLB1 and MLB2 persistent infection after 227 
several cell passages. Addition of IFN-λ1 did not eliminate viral replication completely, 228 
but reduced viral titer 0.96±0.21 and 2.37±0.09 log10 for MLB1 and MLB2, 229 
respectively, after 7 passages (Figure 9C and 9D). In opposite, in the A549 230 
persistently-infected cell cultures, addition of none of the tested IFNs produced an 231 
inhibitory effect on viral replication (Figure 9E and 9F). Increase of IFN concentration 232 
up to 5,000 U/ml for two additional passages had no effect either (data not shown). 233 
 234 
Discussion 235 
We provide the first description of several cell culture systems permissive for the novel 236 
HAstV MLB replication. Both HuH-7 and A549 cell lines were infected by viruses 237 
present in clinical specimens and sustained viral replication during serial cell passages 238 
without addition of viral inoculum. Expressed viral capsid protein was detected by 239 
immunofluorescence within persistently infected cultures and viral capsids were 240 
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visualized by electron microscopy both within membrane vesicles and in the cell 241 
cytosol. The production of infectious virions released into the supernatant of 242 
persistently infected cultures was confirmed by their ability to acutely infect naïve cells 243 
when used as inoculum, and generate virions that could be observed in the cell culture 244 
media after negative staining. In addition, we provide data on replication of two distinct 245 
genotypes, allowing to compare the behaviors of HAstV MLB1 and MLB2. 246 
Nevertheless, we cannot exclude that the results could be strain-dependant, as we only 247 
succeeded in propagating one strain of each genotype. 248 
We found that the addition of exogenous trypsin is not required for efficient replication 249 
of MLB strains, as previously described for VA1 strains by Janowski et al (45). The 250 
efficient propagation of HAstV MLB in extra-intestinal cell lines, hepatic and 251 
respiratory, reinforces this information, as these tissues do not secrete as much trypsin 252 
as the intestinal tract (48). The capacity of novel HAstVs to infect tissues without the 253 
need for capsid activation by trypsin opens the door to a potential wider tissue tropism 254 
in vivo, which could explain the diverse clinical manifestations that have been recently 255 
described with divergent astrovirus strains: acute hepatitis, respiratory illnesses, gout, or 256 
encephalitis. Nevertheless, our attempts to infect CaCo-2 cells were unsuccessful (or at 257 
least not as efficient as with HuH-7 and A549 cells, according to the persistent infection 258 
assays), which distinguish our results from those of Janowski et al and those on 259 
classical astroviruses. Whether this difference is strain-dependent cannot be formally 260 
ruled out, but the hypothesis that divergent astroviruses could show an exclusively 261 
extra-intestinal tropism has also been advanced by other groups (49), who found porcine 262 
astrovirus genome in the central nervous system, respiratory tract and circulatory 263 
system of pigs affected by a neurologic syndrome, but not in stool samples. Their work 264 
suggests that the respiratory tract could be the primary site of astrovirus infection, 265 
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before spreading to the central nervous system. Of note, classical and VA1 astroviruses 266 
are also able to infect A549 cells (45, 50). 267 
Apart from providing a cell culture system for HAstV MLB propagation, we have 268 
identified the capacity of this clade to establish persistent infection in the studied 269 
continuous cell lines. To the best of our knowledge, this is the first description of an 270 
experimentally proven persistent infection for astroviruses. RNA viruses make use of 271 
several mechanisms for persistence – including the innate immune system evasion - and 272 
most of persistent infections are asymptomatic (51, 52). Thereby, although continuous 273 
cell lines are not the best model to infer issues related to pathology occurring in vivo, it 274 
would be very interesting to further study if there is any role for persistent infection in 275 
astrovirus diseases, and if so, which are the determinants for the virus to switch from 276 
persistence to virulence. Our immunofluorescence assay and structural changes 277 
observed by electron microscopy indicate a carrier-state infection, characterized by a 278 
few proportion of capsid-expressing cells, associated with a high degree of cell damage 279 
and a high production of virus progeny (53) that can infect surrounding non-infected 280 
cells. This model of infection is well described for group B coxsackie viruses (54, 55). 281 
An alternate hypothesis is that most of cells in the culture may be resistant to a full 282 
cycle of viral replication – precluding to capsid visualization by immunofluorescence - 283 
and continue to divide. In light of the impossibility to establish a MLB2 persistent 284 
infection in HuH-7.5 cells, it seems that the high rate of replication of MLB2 genotype 285 
during the acute infection prevents the survival and regrowth of the infected cells after 286 
subculture.   287 
The results of our IFN experiments provide clues to understand the mechanism for 288 
HAstV MLB persistence, suggesting that MLB infection does not induce an early strong 289 
IFN expression, as it has already been described for the classical HAstVs (56). This 290 
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would avoid a complete clearance of infection by cells and enable persistence. The fact 291 
that no IFN expression was observed in any acutely infected cell line before 4 dpi, the 292 
time point when infected cultures were subcultivated from C-P0 to study persistence, 293 
supports this idea, permitting the virus to continue replicating in permissive cells before 294 
the intervention of the innate immune response. Only a certain level of IFN-β mRNA 295 
expression was detected in A549 cells during the late course of acute infection. The 296 
inhibition of HAstV MLBs replication with exogenous IFN during acute infection also 297 
reinforces these data: if there was no shut down of IFN expression, efficient production 298 
of IFN by infected cells would inhibit viral replication and thus possibly prevent 299 
persistent infections. Of note, sensitivity of astroviruses to IFN when cells are pre-300 
treated before infection has also been demonstrated for classical HAstV (56, 57) and 301 
VA1 astroviruses (45). 302 
Exogenous IFNs, especially IFN-β1a, were also able to inhibit and even eliminate MLB 303 
viruses from persistently infected cultures, but this was only observed for HuH-7AI 304 
cells and not for A549 cells. While this difference based on cell type was unexpected, it 305 
suggests that persistence may be maintained in both cell lines by dissimilar 306 
mechanisms. Indeed, the inhibitory effects of both IFNs on A549 cells were also 307 
significantly milder than on HuH-7AI when cells were acutely infected. It is also 308 
noteworthy that the effect of MLBs replication on IFN mRNA expression induced by 309 
polyI:C transfection was different in both cell lines. While it could be efficiently 310 
blocked on A549 cells, this effect was only partial in HuH7-AI. Our hypothesis is that 311 
while MLBs cannot inhibit IFN expression induced by polyI:C, they may still avoid 312 
activation of IFN response by an unknown mechanism, allowing their persistence in the 313 
culture unless IFN is added exogenously. On A549 cells, however, MLBs may find the 314 
mechanisms to inhibit both arms of the IFN response (induction and action), allowing 315 
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them to persist in the culture. The fact that efficient counteracting IFN action on A549 316 
cells is only observed when cells are already infected and not when they are acutely 317 
infected suggests that a factor expressed at late stages of the replication cycle may be 318 
required. 319 
Whether our inability to establish a persistent infection on HuH-7.5 cell line with the 320 
MLB2 strain was due to the activation of other cellular innate responses that would 321 
induce expression of antiviral genes in non-infected neighboring cells or whether it was 322 
due to technical factors such as the schedule of culture passaging or to the MOI remains 323 
to be elucidated. In addition, we did not measure other types of IFN such as IFN-α, 324 
which could also play a role in the course of HAstV infection. Altogether, we can see a 325 
distinct IFN expression and response to exogenous IFN between the persistent versus 326 
acute infection, between MLB1 and MLB2 and between different cell lines. These 327 
results suggest that there is an actual co-evolution between a virus and its host and that 328 
many factors (virus strain, cell type, model of infection) may uniquely influence the 329 
course of the infection. Interestingly, Nice et al. recently demonstrated that IFN-λ was 330 
able to reduce and to cure persistent infection of murine norovirus in the absence of an 331 
adaptive immune response (58, 59), and that the interaction between host IFN-λ 332 
response and some viral nonstructural proteins determined viral tropism (59). In 333 
addition, these results also suggest that, if persistence was confirmed in vivo, in case of 334 
co-infections, certain MLB HAstVs could potentially promote the replication of other 335 
viruses by inhibiting IFN response.  336 
In summary, we provide a cell culture system for the propagation of the novel HAstV 337 
MLB. We have demonstrated that these viruses can establish a carrier-state infection in 338 
vitro on extra-intestinal human cell lines. IFN expression may be altered by HAstV 339 
MLB infections although may vary depending on the strain, the cell line and the model 340 
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of infection. Finally, HAstV MLB sensitivity to IFN also depends on the type of 341 
infection, the genotype, the cell line and the type of IFN.  342 
 343 
Materials and Methods 344 
Cell lines 345 
Human epithelial colorectal adenocarcinoma (CaCo-2 cells; ECACC 86010202), human 346 
hepatocyte-derived cellular carcinoma (HuH-7AI cells (60) and HuH-7.5 cells (61)) and 347 
adenocarcinoma human alveolar basal epithelial (A549 cells; ATCC-CCL 185) cell 348 
lines were grown at 37°C with 5% C02, on  MEM with L-glutamine supplemented with 349 
10% of fetal bovine serum (FBS; Gibco) and 100 units/mL of penicillin and 350 
streptomycin (Gibco). 351 
Clinical specimens 352 
Stool samples positive for MLB1 were collected during a screening of stool samples in 353 
children under 5 years old with acute gastroenteritis in Barcelona, Spain. Stool samples 354 
positive for MLB2 were identified in a previous study (28). Three samples positive for 355 
MLB1 and three samples positive for MLB2 were used for infection, with a viral titer 356 
ranging from 1.5x10
6
-1.2x10
8
 genome copies/ml of inoculum for MLB1 and from 357 
2.8x10
4
-4.6x10
7
 genome copies/ml of inoculum for MLB2.  358 
Acute infections 359 
Stool suspensions of 0.1 g of stool sample diluted in 900 µl of PBS were filtered 360 
through a 0.45 µm filter (Millipore) and then diluted 1:2 with MEM 0% FBS, and were 361 
used as initial inoculum. The inoculum was pretreated with trypsin (Gibco), at a final 362 
concentration of 10 µg/ml, at 37°C for 30 minutes. Cells were grown on a 24-well plate 363 
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to 80-100% confluency and washed twice with MEM 0% FBS before infection with 200 364 
µl of the stool inoculum diluted 1:2 after trypsin pretreatment. Cells were incubated for 365 
one hour at 37°C and the inoculum was then removed and replaced by 500 µl of MEM 366 
0% FBS supplemented with 0.03% kanamycin, penicillin and streptomycin, and 5µg/ml 367 
trypsin. Cells were maintained at 37°C and 5% CO2 for 7 days and the medium was 368 
changed every other day. After 7 days, cells were freezed/thawed three times and 100 µl 369 
of the cell lysate was used for the next viral passage. Subsequent viral passages (V-P) as 370 
acute infections were performed without trypsin pre-treatment and with addition of 371 
MEM supplemented with 10% FBS without trypsin in the post-infection media. 372 
Persistent infections 373 
A cell lysate of the viral passage 7 (V-P7) of the acute viral passages on HuH-7.5 cells 374 
was used to persistently infect the HuH-7AI, A549 and CaCo-2 cell lines with MLB1 375 
and MLB2, respectively (Figure 1B). The viral titer in these selected cell lysates was 376 
determined as viral genome copies/ml by RTqPCR assay, and as infectious viruses/ml 377 
by TCID50 assay in HuH-7.5 cells. Briefly, for TCID50 assay, cells were infected with 378 
10-fold serial dilutions of each sample in quadruplicate, as described above for acute 379 
infections. After 7 days, nucleic acids were extracted from 50 µl of supernatant from 380 
each well and a RT-qPCR assay was performed for the detection of viral genomes (see 381 
below). The TCID50 was calculated using the Spearman-Karber method, with any 382 
detection of viral genome in a well being considered as infected. 1 TCID50 corresponded 383 
approximately to 1.4x10
4
 genomes for MLB1 and to 1.5x10
3
 for MLB2. A multiplicity 384 
of infection (MOI) of approximately 1,000 genome copies per cell (0.07 infectious 385 
viruses per cell) and 20 genome copies per cell (0.01 infectious viruses per cell) was 386 
used for MLB1 and MLB2, respectively. For the first passage, cells were grown on 24-387 
well plates to 80-100% confluency and washed twice with MEM 0% FBS. Cell lysates 388 
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were diluted in MEM 0% FBS to a final volume of 200 µl at the desired MOI and was 389 
inoculated to the cells. After 1-hour incubation at 37°C, the inoculum was removed and 390 
replaced by 500 µl of MEM 10% FBS. There was no pretreatment or addition of trypsin 391 
for the persistent infections. Cells were incubated at 37°C for 4 days before being 392 
subcultivated by trypsinization at a split ratio 1:3 for a subsequent passage. Cells were 393 
then subcultivated by trypsinization for serial passages without addition of viral 394 
inoculum. Persistently infected cells were maintained in T75 flasks, and subcultivated 395 
every 7-10 days at a split ratio 1:3-1:6. An aliquot of the supernatant before each 396 
subculture was collected to monitor viral titer. 397 
Viral RNA extraction and quantitative reverse-transcription polymerase chain 398 
reaction (RT-qPCR) assay 399 
RNA was extracted from the cell culture supernatants using the NucleoSpin® RNA 400 
virus kit (Macherey-Nagel) following the manufacturer’s instruction, and RT-qPCR 401 
specific assays for MLB astroviruses were performed as previously published (19). 402 
Briefly, the following primers and probe for MLB1 were used: forward primer 4320: 5’-403 
GGTCTTGGAGCYCGAATTC-3’; reverse primer 4387: 5’  404 
CGCTGTTTAATGCGCCAAA 3’; hydrolysis probe 4349: 5’ [FAM] 405 
TAGRGTTGGTTCAAATCT [MGBNFQ] 3’. The primers and probe used for MLB2 406 
were as follows: forward primer 3762: 5’ CCGAGCTCTTAGTGATGCTAGCT 3’; 407 
reverse primer 3832: 5’ CACCCCTCCAAATGTACTCCAA 3’; hydrolysis probe 3793: 408 
5’ [VIC] CGCTTCACTCGGAGAC [MGBNFQ] 3’. Plasmids containing a 125 bp-409 
fragment of the MLB1 (spanning nucleotides 4292-4416 from FJ222451) and MLB2 410 
(spanning nucleotides 3724-3848 from KT224358) genomes were used as controls for 411 
quantification, and RT-qPCR was performed using the Kapa Probe Fast Universal One-412 
Step RT-qPCR Master Mix (Kapa Biosystems) following the manufacturer’s 413 
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instructions, on a CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad). 15 µl 414 
of the RT-qPCR master mix were mixed with 5 µl of extracted RNA. The reaction 415 
conditions were as follows: 42°C for 15 minutes, 95°C for 5 minutes, then 40 cycles of 416 
95°C for 3 seconds, 55°C for 20 seconds, 72°C for 10 seconds. Standard curves were 417 
constructed based on 10-fold serial dilutions of the corresponding MLB plasmid 418 
analyzed in duplicate. 419 
Multistep growth curve 420 
The multistep growth curve was performed using a MOI of 20 genome copies/cell for 421 
both MLB1 and MLB2. Infection was performed on 24-well plates according to the 422 
protocol used for acute infection (without the use of trypsin nor the change of medium 423 
every other day). At each indicated time point, 50µl of the supernatant as well as the 424 
total cells were collected. RNA extraction of the supernatant was performed using the 425 
NucleoSpin® RNA virus kit (Macherey-Nagel) following the manufacturer’s 426 
instruction, and RNA extraction from cells was performed using the GenElute 427 
Mammalian Total RNA Miniprep Kit (Sigma Aldrich), as indicated by the 428 
manufacturer’s instruction. RT-qPCR assay was performed as described above. Samples 429 
were quantified in triplicate from one single experiment. 430 
Immunofluorescence 431 
Indirect immunofluorescence assays were performed using rabbit polyclonal MLB1 432 
capsid peptide (DW60) and MLB2 capsid peptide (DW58) antibodies (kindly provided 433 
by Dr David Wang, Washington University School of Medicine) (62) as primary 434 
antibodies, and secondary antibodies labeled with Alexa 488. DAPI staining was used 435 
to detect nuclei. Briefly, cells were rinsed twice with PBS and fixed with 3% 436 
paraformaldehyde in PBS for 15 minutes (min) at room temperature (RT). 437 
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Permeabilization was performed for 10 min at RT with 0.5% Triton X-100 in 20mM 438 
glycine-PBS. Cells were then blocked for 60 min at RT in 20mM glycine-PBS 439 
containing 10% bovine serum albumin, before incubation with primary antibodies with 440 
a 1:1000 dilution during 60 min at 37°, and then with the secondary antibodies with a 441 
1:500 dilution during other 60 min at 37°. Incubation with 1µg/ml DAPI (4’,6’-442 
diamidino-2-phenylindole) staining was finally performed for 15 min at RT. Cells were 443 
washed twice after each step described, except between the blocking step and the 444 
incubation with primary antibodies and were kept in PBS at 4° until visualization. 445 
Negative controls included cells incubated with pre-immune sera, primary or secondary 446 
antibodies alone, and fixed cells alone (sample auto-immunofluorescence). Nuclei and 447 
viral capsids were visualized under a Leica DMIRB/MZFLIII fluorescence microscope. 448 
Electron microscopy 449 
Cell culture supernatants were analyzed by transmission electron microscopy after 450 
negative staining. A 10-µl sample was applied to a carboncoated 400-mesh copper grid 451 
and was stained with 2% phosphotungstic acid at pH 6.4. The grids were examined 452 
under a JEOL 1200 electron microscope.  453 
For ultrathin sections, persistently infected cells and non-infected controls were seeded 454 
on a 90 mm sterile dish for cell culture until reaching 80-90% confluency. After 455 
removing the medium, cells were fixed with 2.5% glutaraldehyde in 0.1 M phosphate 456 
buffer (PB) during 60 minutes. Cells were then scrapped in 1.5 ml of PB and collected. 457 
After 10 minutes centrifugation at 1000 g, the pellet was suspended in PB and washed 458 
in agitation at 4°C during 10 minutes (x4).  Cells were then post-fixed with 1% osmium 459 
tetroxide, 0.8% potassium hexacyanoferrate in 0.1 M PB for 1-2 hours at 4°C. After 460 
extensive washing with Mili-Q water, sample dehydratation was performed with a 461 
graded series of acetone (50% to 100%) and blocs were prepared in Eponate 12. 462 
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Sections of 55 nm were cut with a Leica UC6 ultramicrotome (Leica Microsystems 463 
Inc.). Observation was performed under a JEOL 1200 electron microscope. 464 
Sequence analysis 465 
Primers pairs were designed to amplify ten overlapping amplicons covering the 466 
complete genomes (Table 2). Reverse transcription was performed using the 467 
Superscript IV Reverse Trancriptase (Invitrogen) and cDNA amplification was 468 
performed using the Pwo DNA polymerase (Roche), at the following reaction 469 
conditions: 70°C for 7 minutes, 50°C for 25 minutes, 80°C for 10 minutes; 94°C for 4 470 
minutes, then 40 cycles of 94°C for 30 seconds, 50-55°C for 40 seconds, 72°C for 2.15 471 
minutes, and 72°C for 10 minutes. Amplicons were purified by gel electrophoresis and 472 
Sanger sequenced with the ABI PRISM BigDye® Terminator Cycle Sequencing Ready 473 
Reaction Kit V3.1on an ABI Prism 3700 automatic sequencer (Applied Biosystems). 474 
Complete genome sequences for the MLB1 strain obtained from the stool specimen was 475 
deposited in Genbank (Accession numbers MK089434 and MK089435). 476 
IFN expression analysis 477 
Intracellular RNA was extracted using the GenElute Mammalian Total RNA Miniprep 478 
Kit (Sigma Aldrich), as indicated by the manufacturer’s instruction.  The resulting 479 
eluate was treated with RQ1 RNAse-free DNase (Promega) to remove any trace of 480 
genomic DNA. Quantitative reverse-transcription polymerase chain reaction (RT-481 
qPCR) was performed using the manufacturer’s instructions for KiCqStart One-step 482 
Probe RT-qPCR assay targeting mRNA of GAPDH, IFN-β and IFN-λ1 on a CFX96 483 
Touch™ Real-Time PCR Detection System (Bio-Rad).  Primers and probes sequences 484 
were as follows: GAPDH forward primer: 5’-GAAGGAAATGAATGGGCAGC-3’, 485 
GAPDH reverse primer: 5’-TCTAGGAAAAGCATCACCCG-3’, GAPDH probe: 5’- 486 
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[6FAM]ACTAACCCTGCGCTCCTGCCTCGAT[OQA]-3’; IFN-β forward primer: 5’- 487 
CCTCCGAAACTGAAGATC-3’, IFN- β  reverse primer: 5’-488 
GCAGTACATTAGCCATCA-3’, IFN- β probe: 5’-489 
[FAM]TAGCCTGTGCCTCTGGGACT[BHQ]-3’; IFN-λ1 forward primer: 5’-490 
CCACCACAACTGGGAAGG-3’ IFN-λ1 reverse primer: 5’-491 
TTGAGTGACTCTTCCAAGGC-3’ IFN-λ1 probe: 5’-492 
[FAM]AGCGAGCTTCAAGAAGGCCAGGGAC[OQA]-3’. 15 µl of the RT-qPCR 493 
master mix were mixed with 5 µl of extracted RNA. The reaction conditions included: 494 
50°C for 20 minutes, 95°C for 1 minute, then 40 cycles of 95°C for 5 seconds and 60°C 495 
for 35 seconds. GAPDH mRNA titers were used as an endogenous control to normalize 496 
all samples versus the number of cells. All samples were quantified at least in duplicate 497 
from two distinct experiments. Positive controls were determined by the transfection of 498 
the synthetic analog of dsRNA polyinosine-polycytidylic acid (polyI:C) (InvivoGen) at 499 
1mg/ml on each cell line, using the X-treme HD Roche transfection reagent (Roche) and 500 
Optimem Medium (Gibco). Determination by RT-qPCR assay of the IFN expression 24 501 
hours after transfection was then performed as described above. To define a standard 502 
curve, 10-fold serial dilutions of the GAPDH, IFN-β and IFN-λ1 RNA were analyzed 503 
for each cell line transfected with polyI:C.  504 
Inhibition of MLB HAstV replication with addition of exogenous IFN  505 
We used human IFN-β1a and IFN-λ1 (PBL Assay Science). For the acute infection, 506 
cells were grown on a 24-well plate and were pretreated with IFN-β1a or IFN-λ1 at a 507 
concentration of 1,000 U/ml for 24 hours before infection. Cells were inoculated with 508 
MLB1 and MLB2 at a MOI of 20 genome copies/cell as described before (without the 509 
use of trypsin). IFN-β1a or IFN-λ1 were added in the post-infection medium at a 510 
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concentration of 1,000 U/ml. 50 µl aliquots were collected from the supernatant at 4dpi 511 
for RNA extraction and RT-qPCR (see above).  512 
For persistent infection, persistently-infected cell cultures were subcultured as described 513 
before. IFN-β1a or IFN-λ1 were added in the medium post-seeding at a concentration of 514 
1,000 U/ml. 50 µl of supernatant was collected before the next subculture, between 4 515 
and 6 days post-seeding, and viral RNA was extracted and analyzed by RT-qPCR as 516 
described before. All passages were performed in duplicate. 517 
Statistical analyses 518 
The Mann-Whitney and ANOVA tests, with additional test of Scheffe when 519 
appropriate, were used to compare continuous variables. P<0.05 was considered 520 
statistically significant. Statistics were performed by Stata /IC 13.1 (StataCorp, College 521 
Station, TX, USA). 522 
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Table 1: Summary of the results of HAstV MLB1 and MLB2 propagation on 720 
selected cell lines 721 
 HAstV MLB1 HAstV MLB2 
Origin of the stool sample 1 year-old child 
Barcelona, Spain 
Adult allogeneic stem 
cell transplant recipient 
for acute myeloid 
leukemia 
Geneva, Switzerland 
Patient’s symptoms Gastroenteritis Meningo-encephalitis 
Leukemia relapse 
Viral titer of the initial inoculum 
(genome copies/ml) 
7.9x10
7
 4.6x10
7
 
Acute infections 
Infected cell lines 
 CaCo-2 cells - ND 
 HuH-7.5 cells + + 
 HuH-7AI cells + + 
 A549 cells + + 
Mean viral titers (genome copies/ml of SN) 
 HuH-7.5 cells 4.5x106 2.8x109 
Persistent infections 
Infected cell lines 
 CaCo-2 cells - ND 
 HuH-7.5 cells + - 
 HuH-7AI cells + + 
 A549 cells + + 
Mean viral titers (genome copies/ml of SN) 
 HuH-7.5 cells 5.6x109 - 
 HuH-7AI cells 4.3x108 3.6x107 
 A549 cells 4.9x108 2.5x107 
Percentage of infected cells (median) 
 HuH-7AI cells 11% 8.8% 
 A549 cells 4.8% 8.8% 
 722 
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Mean viral titers for HuH-7AI and A549 cell lines acute infections are not provided due 723 
to the few number of assays performed. ND: not done; + successful replication; - failure 724 
to replicate. 725 
 726 
  727 
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Table 2. Nucleotide sequences of the primers pairs used for the sequencing of the whole 728 
genomes of HAstV MLB1 and HAstV MLB2 strains recovered from infected cells.  729 
Segment Primer MLB1 MLB2 
Segment 1 Primer 1 F CCAAGAGTGGTGGTATGGC CCAAGAGTGGTGGTATGGC 
 Primer 1 R CAGTGCTGTAGACATCCAGAAA AGCACAAACAACTGATGTAACT 
Segment 2 Primer 2 F AGAGACCCTGTGTTGCAATAAT AAAGACCATGTGTTGCCATAAT 
 Primer 2 R CTAACTTTGGCTTGAGCAACATAA CTAACTTTAGCCTGGGCCACATAA 
Segment 3 Primer 3 F CATAGTTACCGCCGCACAT TATAGTGACAGCAGCACAT 
 Primer 3 R TTCCCTAGTCAGTCCCTTATCC TTCTCTGGTTAGGCCTTTATCC 
Segment 4 Primer 4 F CTGACAGAAGAGGAGTACCAAG TGGCGCACGTCATAGAA 
 Primer 4 R CCCATACAGTGGGACCAAA CCCATACAGTGGGACCAAA 
Segment 5 Primer 5 F GTACCTTTAGATAGGCCAGTGTATG GTACCTTTAGATAGGCCAGTGTATG 
 Primer 5 R CATCAACAAGGTTGGTGGTATTG CACCCATAAGCGAGAACCGTAAT 
Segment 6 Primer 6 F GTTGCGCTCCAAAGGTAATAAA TCCCTTCTTTGGAGGCTTTG 
 Primer 6 R AGTGAAGCGCCTTGGTAAG AGTGAAGCGCCTTGGTAAG 
Segment 7 Primer 7 F CCAGTTGTTGATGGCAAATGA CCAGTTGTTGATGGCAAATGA 
 Primer 7 R CCACTCACTAGACGCTGTTT TTCACAAGGGCCTGAAAC 
Segment 8 Primer 8 F CTCAACTCATGGTCTGGTCTTG TTGAATTCATGGTCGGGTC 
 Primer 8 R CATGTGCCTTGCTGGAAATTG GGTGGGCAGTACTAGAAATTG 
Segment 9 Primer 9 F CAGCGGATGTCTATCGTGTTTA CAGCTGATGTTTACAGAGTTTACAC 
 Primer 9 R TCCTTAGGTATAGCTGGGTATGT AATGACCCTGTATGCTGGTATG 
Segment 10 Primer 10 F GGTCATCAGCACCAGCTAATA GTTCATCTGCAACATCTGAGA 
 Primer 10 R TTTTTTTTTTTTTTTTTTTTTTTTTTTTT
TTTTTTTT 
TTTTTTTTTTTTTTTTTTTTTTTTTTTT
TTTTTTTTT 
 730 
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Figure legends 733 
Figure 1. Description of the viral and cell passages performed with HAstV MLB1 734 
and MLB2 on selected cell lines. (A) Passage history in HuH-7.5 cells. Initially, cells 735 
were infected using clinical stool samples as inoculum. After 7-8 viral passages of 736 
HAstV MLB1 and MLB2, respectively, infected cells were subcultured. (B) HuH-7AI 737 
and A549 cell passages using HuH-7.5 cell lysates as inoculum to establish persistent 738 
infections. V-Pn: viral passages; C-Pn: cellular passages; EM: electron microscopy; IF: 739 
immunofluorescence; IFN: interferon. 740 
Figure 2. Infection of MLB1 and MLB2 in acutely infected cells. (A) Viral genome 741 
titers detected in the culture supernatant (SN) by RT-qPCR assays.  (B and C) Electron 742 
microscopy of SN from HuH-7.5 cells infected with HAstV MLB1, using SN of a 743 
persistently-infected cell line as inoculum (B) and MLB2 (C). Bars equal 200 nm. 744 
Figure 3. Multi-step growth curves of MLB1 and MLB2 on HuH-7.5 cells. Cells 745 
were infected using a multiplicity of infection of 20 genome copies/cell, and viral RNA 746 
was measured from the cellular (A) and supernatant fractions (B). Plot shows average 747 
values and error bars indicate one standard deviation from triplicates. (C) Viral 748 
replication with or without trypsin for MLB1 and MLB2 on HuH7.5 cells. Viral 749 
replication is expressed as the fold induction of viral genome titers in the SN of infected 750 
cells from 1 hpi to 7 dpi.  P values comparing fold inductions with and without trypsin 751 
for each genotype were not significant (Mann-Whitney test). Plot shows average values 752 
and error bars indicate one standard deviation. Samples were quantified in duplicate 753 
from one single experiment.  754 
Figure 4. Electron microscopy analysis of the persistent infections on HuH-7.5 755 
cells. (A) Non-infected HuH-7.5 cells (B-F) and persistently infected HuH-7.5 cells), 756 
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showing intracellular capsid arrays of HAstV MLB1, at 4 days post-seeding. 757 
Aggregates of astrovirus particles (v) accumulated in the cytoplasm of infected cells 758 
around the nuclei (N). Bars equal 5 µm in A and B, 2 µm in C, and 1 µm in D, E and 759 
200 nm in F.  760 
Figure 5. Viral genome titers detected in the culture supernatant (SN) by RT-761 
qPCR assays of MLB1 and MLB2 strains in persistently infected cell lines. (A) 762 
Blue line refers to HuH-7.5 cell line, red lines refer to HuH-7AI cell line, green lines 763 
refer to A549 cell line and orange line refer to CaCo-2 cell line. Continuous lines with 764 
squares refer to HAstV MLB1 strain and dotted lines with triangles refer to HAstV 765 
MLB2 strain. The dotted blue line with squares corresponds to the MLB1 persistently-766 
infected HuH-7.5 cell line, using the original stool sample as inoculum. (B) Mean viral 767 
genome titers of HAstV MLB1 and MLB2 detected by RT-qPCR assays in the SN of 768 
persistently infected HuH-7AI and A549 cell lines. The average was calculated based 769 
on 7-12 numbers, corresponding to the viral genome titers at each cell passage. Error 770 
bars indicate one standard deviation. The mean viral titers were significantly different 771 
between HAstV MLB1 and HAstV MLB2, when comparing the same infected cell line 772 
(*p=0.0009 in HuH-7AI cells, p=0.0018 in A549 cells, Mann-Whitney test).  773 
Figure 6. Immunofluorescence assay of MLB1 and MLB2 persistently infected cell 774 
lines. (A) Infected and non-infected (mock) cultures were fixed at confluency and were 775 
incubated with primary (anti-MLB1 and anti-MLB2 antibodies, respectively) and 776 
secondary antibodies. Green color corresponds to the viral capsid proteins, and blue 777 
color to the nuclei. All samples were fixed at 3-5 days post-seeding (magnification, x10-778 
20). (B) Estimated proportion of persistently infected cells visualized by the 779 
immunofluorescence assay. Central line of each box plot represents the median. Each 780 
boxplot includes data from 7-12 fields, from 2 different cell passages. For HAstV 781 
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MLB1, the proportion of HuH7-AI infected cells was significantly higher than the 782 
proportion of A549 cells (*p=0.0267, Mann-Whitney test). Bars equal 25 µm. 783 
Figure 7. Visualization of capsid arrays by electron microscopy of persistently 784 
infected HuH-7AI and A549 cells. (A) Non-infected HuH-7AI cells, (B) Non-infected 785 
A549 cells, (C) HuH-7AI cells persistently-infected with HAstV MLB1, and (D) A549 786 
cells persistently-infected with HAstV MLB2. Bars equal 2 µm in main images and 200 787 
nm in enlargements. 788 
Figure 8. IFN-β and IFN-λ1 expression in infected cell lines. (A) Temporal analysis 789 
of IFNβ and IFN-λ1 mRNA expression during acute infection in HuH-7 and A549 790 
cells. Cells were infected with a MOI of 1,000 and 20 genome copies/cell for MLB1 791 
and MLB2, respectively, and polyI:C-transfected cells were used as controls. (B, C) 792 
Immunofluorescence images correspond to an acute infection using the highest MOI 793 
possible (25,000 genome copies/cell for MLB1 and 680 genome copies/cell for MLB2). 794 
(D) Analyses of IFN-β and IFN-λ1 expression in persistently-infected cultures. 795 
Mock are non-infected cells. Mock-poly I:C are non-infected cells transfected with 796 
polyI:C (positive control). Persistent are persistently-infected cells. Persistent-polyI:C 797 
are persistently infected cells that were additionally transfected with polyI:C. 1d, 2d, 4d 798 
and 7d are the days post-infection (dpi) where IFN expression was measured during 799 
acute infections. All samples were quantified at least in duplicate from two distinct 800 
experiments. 801 
Figure 9. Effect of exogenous IFN during acute infection (A, B) and in persistently-802 
infected cultures (C-F). Effect of exogenous IFNβ-1a and IFN-λ1 on acutely-infected 803 
HuH-7AI and A549 cells by MLB1 (A) and MLB2 (B). The graphic illustrates the mean 804 
viral titer measured in the supernatant at 4 dpi, and error bars show one standard 805 
deviation. There was a statistically significant difference in the viral titer between no 806 
 o
n
 April 30, 2019 by guest
http://jvi.asm.org/
D
ow
nloaded from
 
34 
 
IFN and IFN-β1a and between no IFN and IFN-λ1 (*p<0.01, ** p<0.005, ***p<0.001, 807 
ANOVA and Scheffe tests). Effect of exogenous IFN-β1a and IFN-λ1 on HuH-7AI 808 
cultures persistently infected with MLB1 (C) or MLB2 (D), and on A549 cultures 809 
persistently infected with MLB1 (E) and MLB2 (F). Data represent the mean±standard 810 
deviation titer of viral RNA in the supernatant of each passage measured at 4-6 days 811 
post-seeding in the presence or absence of exogenous IFN-β1a or IFN-λ1. All passages 812 
were performed in duplicate. P0 corresponds to the viral titer at one day after seeding of 813 
the first passage with exogenous IFN. Dotted line indicates the limit of detection. 814 
P=passage; SN=supernatant. 815 
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